MILESTONE PHARMACEUTICALS - ONGOING PHASE 3 TRIAL FOR ETRIPAMIL NASAL SPRAY IN AFIB-RVR ON SCHEDULE; TOPLINE DATA EXPECTED 2H 2028

Reuters · 3d ago

Please log in to view news